tiprankstipranks
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
Holding OLMA?
Track your performance easily

Olema Pharmaceuticals (OLMA) Financial Statements

649 Followers

Olema Pharmaceuticals Financial Overview

Olema Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.189; its P/E ratio is -3.98; Olema Pharmaceuticals is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -34.55M$ -30.38M$ -30.97M$ -30.42M$ -23.34M
EBITDA$ -34.17M$ -30.00M$ -30.59M$ -30.33M$ -23.25M
Net Income Common Stockholders$ -34.55M$ -30.38M$ -30.97M$ -26.77M$ -21.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 214.76M$ 239.10M$ 248.98M$ 261.81M$ 276.90M
Total Assets$ 230.17M$ 254.56M$ 263.69M$ 276.94M$ 292.80M
Total Debt$ 1.70M$ 1.96M$ 2.21M$ 2.42M$ 2.62M
Net Debt$ -213.06M$ -237.14M$ -246.77M$ -259.39M$ -274.28M
Total Liabilities$ 31.26M$ 27.39M$ 27.38M$ 23.05M$ 17.66M
Stockholders Equity$ 198.91M$ 227.16M$ 236.32M$ 253.90M$ 275.13M
Cash Flow-
Free Cash Flow$ -27.02M$ -27.56M$ -23.65M$ -18.48M$ -22.74M
Operating Cash Flow$ -27.02M$ -27.55M$ -23.50M$ -18.48M$ -22.74M
Investing Cash Flow$ 45.92M$ -4.88M$ -20.14M$ -30.91M$ -25.44M
Financing Cash Flow$ 92.00K$ 15.61M$ 8.82M$ 523.00K$ 130.63M
Currency in USD

Olema Pharmaceuticals Earnings and Revenue History

Olema Pharmaceuticals Debt to Assets

Olema Pharmaceuticals Cash Flow

Olema Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis